About: Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1997 (uk) im Juli 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1997 (ast) scientific article published on 01 July 1997 (en)
publication date	wds:Q73538268-F7F0638B-0BB3-4F36-897D-2CDC241FDF7F
publication date	1997-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73538268-1A0AB59F-CB99-4890-B74B-9F03D0990778 wds:Q73538268-526DE233-1698-4898-913B-C65B8F761BC9 wds:Q73538268-7A2930F0-42C8-42A4-9D64-CFA803C47433 wds:Q73538268-8EF0547C-D089-480E-9E50-6D92686B43DC wds:Q73538268-DC58BE9D-7812-4A28-B427-9CE5ABE29EB5 wds:Q73538268-F198764F-4041-4FB2-9AA5-284D0651834C
author name string	D R Abernethy S Oparil A M Shepherd M C Reif B S Levine I Kobrin
rdfs:label	Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (en) Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (nl)
skos:prefLabel	Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (en) Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (nl)
name	Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (en) Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (nl)
title	wds:Q73538268-654ECEFB-C3F6-4937-89A4-A289AD7E4798
title	Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (en)
page(s)	wds:Q73538268-772D939A-339E-4EB7-ADE7-8AF4574D5B03
page(s)	735-742
instance of	wds:Q73538268-DB3F3EF9-CE96-4D8E-B2CC-D6830A109AA2
instance of	scholarly article
main subject	wds:Q73538268-C690B07B-6E6C-49B5-BD88-EE553CE5E3CE
main subject	essential hypertension
PubMed ID	wds:Q73538268-7F5960E8-BEFA-44C9-A2A2-978343909C3A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9234827
PubMed ID	9234827
published in	wds:Q73538268-321A71B9-765A-4758-92D7-AF2732EFCBFF
published in	Journal of Clinical Hypertension
issue	wds:Q73538268-302E8303-6B54-4647-A39E-006BA519A530
volume	wds:Q73538268-90335E8D-7B83-4628-837C-200A81941B3A
issue	7 Pt 1
volume	10
DOI	wds:Q73538268-59810406-EEC2-4B65-8AB2-2FB84BCB045A
DOI	http://dx.doi.org/10.1016/S0895-7061(97)00092-7
DOI	10.1016/S0895-7061(97)00092-7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73538268
is cites work of	Torsades de pointes caused by Mibefradil Mibefradil: a selective T-type calcium antagonist Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CD. Mibefradil Hypertension Study Group Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists
is cites work of	wds:Q41647645-0A85233A-543D-49D6-8F66-4970DDE9834B wds:Q46225801-398CAB47-3395-4ADC-BAD8-D717BDA0AC35 wds:Q28373565-5883F134-4C2E-4E2B-BBDC-DD8C41496A09 wds:Q41634924-6EA49C4B-BF86-4966-A45E-4DC3E5DAAE5B wds:Q42546276-62E89668-9FE9-46AB-9786-5372252C9F44 wds:Q54616735-6E57CB3E-8EF5-4F3E-9866-CCAC7E2CD88C wds:Q74787363-7E16BD08-6F94-43BE-84D8-275DEF642FB0 wds:Q43762907-ED2721F8-00C5-410D-B79B-167564ACA685 wds:Q73673626-E85C16D8-554D-4195-9906-8FC7DCECA2EB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software